Programs

Acute leukemia remains a devastating disease, especially in adults, with survival rates below 50%. Even for children, where rates are higher, intense chemotherapy often leads to long-term health challenges. The urgency to understand the molecular intricacies of leukemia cells, particularly their differences from normal hematopoietic cells, is paramount.